Kansas City Business Journal: Clinical Trials Deliver a Real Dose of Hope to Cancer Patients

Kansas City Business Journal healthcare reporter, Elise Reuter, examines clinical trial options for cancer patients in Kansas City and interviews Dr. Tim Pluard, Saint Luke's Cancer Institute Medical Director.

Click here for the full story.

Related Content

Thumbnail
Sep. 28, 2017

Saint Luke’s Koontz Center for Advanced Breast Cancer Announces New Clinical Trial for Metastatic Triple Negative Breast Cancer
The clinic will be one of five sites in the United States participating in novel clinical trial designed to test the effectiveness of a new combination of cancer drugs designed to treat triple negative breast cancer.
Thumbnail
May. 23, 2017

Saint Luke's Announces Clinical Trial Affiliation
Saint Luke's triples access to NCI trials with new affiliation. Saint Luke's Health System will broaden its cancer clinical trials through an affiliation with Washington University in St. Louis.

Timothy J Pluard, MD

Oncology / Hematology